Polymerase Chain Reaction Market is Anticipated to Grow US$ 30.3 Bn By 2030

The worldwide Polymerase Chain Reaction market measurement is anticipated to achieve USD 30.3 billion by 2030 and is anticipated to increase at a CAGR of 1.0% from 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38466

Growth Factors

This is driven by an increase in demand for rapid diagnostic tests and technological advancements.Key players operating in the market are focusing on introducing novel and technologically advanced devices for PCR tests. For instance, in July 2017, Bio-Rad Laboratories launched droplet digital PCR Genome Edit Detection Assays to quantify the efficiency of CRISPR-Cas9 or any other genome using the technology of Bio-Rad’s droplet digital polymerase chain reaction. This technology has gained prominence over the past few years. Furthermore, the COVID-19 outbreak has increased the growth rate of dPCR technology. Several types of research activities are being conducted for proving the accuracy of the dPCR test. 

Report Highlights

The others segment dominated the market and accounted for the largest revenue share of more than 95.0% in 2020. The segment includes Real-time PCR (qPCR) and digital PCR, which dominated the overall market in 2020 due to increased adoption and wide applications in research.

The consumables and reagents segment dominated the market and accounted for the largest revenue share of more than 69.0% in 2020. This growth is attributable to a substantial demand for testing supplies for the SARS-CoV-2 pandemic and the increased availability of technologically advanced diagnostic equipment in countries with unmet clinical needs.

The technology is improving and is shifting toward easy-to-use products. For instance, MatMaCorp’s handheld PCR device MYRTA was launched in May 2021 facilitating real-time detection. A new entrant diagnostic system in the segment is the QuantStudio 5 Dx RT-PCR system, which was introduced by Thermo Fisher Scientific in March 2021 for laboratory use as well as assay development.

The medical segment dominated the market and accounted for the largest revenue share of 95.9% in 2020. The segment is anticipated to maintain its dominance over the forecast period due to its advantages in research and other applications, such as detecting and quantifying low-frequency mutations and low levels of pathogens with higher sensitivity. Moreover, increasing adoption in diagnostic centers and hospitals is propelling the growth of the segment.

Increasing adoption of PCR for food safety and detecting infection along with food-borne pathogens and toxicogenic fungi is expected to drive the market. Species identification has become increasingly vital in some applications such as meat species identification.

North America dominated the Polymerase Chain Reaction market and accounted for the largest revenue share of 37.8% in 2020. Favorable government initiatives, coupled with flexible regulatory guidelines are anticipated to propel market growth in North America. For instance, in February 2020, the Department of Health and Human Services announced the authorization of emergency use of diagnostics for detection of COVID-19. This authorization increased the number of diagnostics product launches in the region.

Key Players

  • Abbott
  • Qiagen
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • Fluidigm Corporation
  • Cytiva
  • Stilla Technologies
  • Microsynth AG
  • JN Medsys
  • Danaher Corporation
Report Coverage Details
Market Size US$ 30.3 billion by 2030
Growth Rate CAGR of 1.0% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Type, Product, Application
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Abbott; Qiagen; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; bioMérieux SA; F. Hoffmann-La Roche Ltd.; Agilent Technologies, Inc.; Fluidigm Corporation; Cytiva; Stilla Technologies; Microsynth AG; JN Medsys; Danaher Corporation

Market Segmentation

  • Type
    • Conventional PCR
    • Others
  • Product
    • Consumables & Reagents
    • Instruments
    • Software & Services
  • Application
    • Medical
      • Clinical
        • Pathogen Testing
        • Oncology Testing
        • Blood Screening
        • Others
      • Research
      • Forensic and others
    • Non-Medical
      • Food
      • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38466

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Polymerase Chain Reaction Market, By Type

7.1.  Polymerase Chain Reaction Market, by Type, 2021-2030

7.1.1.    Conventional PCR

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Others

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Polymerase Chain Reaction Market, By Application

8.1.  Polymerase Chain Reaction Market, by Application, 2021-2030

8.1.1.    Medical

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Non-Medical

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Polymerase Chain Reaction Market, By Product

9.1.  Polymerase Chain Reaction Market, by Product, 2021-2030

9.1.1.    Consumables & Reagents

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Instruments

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Software & Services

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Polymerase Chain Reaction Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Type (2016-2030)

10.1.2.  Market Revenue and Forecast, by Application (2016-2030)

10.1.3.  Market Revenue and Forecast, by Product (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Type (2016-2030)

10.1.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.1.4.3.      Market Revenue and Forecast, by Product (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Type (2016-2030)

10.1.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.1.5.3.      Market Revenue and Forecast, by Product (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Type (2016-2030)

10.2.2.  Market Revenue and Forecast, by Application (2016-2030)

10.2.3.  Market Revenue and Forecast, by Product (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Type (2016-2030)

10.2.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.4.3.      Market Revenue and Forecast, by Product (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Type (2016-2030)

10.2.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.5.3.      Market Revenue and Forecast, by Product (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Type (2016-2030)

10.2.6.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.6.3.      Market Revenue and Forecast, by Product (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Type (2016-2030)

10.2.7.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.7.3.      Market Revenue and Forecast, by Product (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Type (2016-2030)

10.3.2.  Market Revenue and Forecast, by Application (2016-2030)

10.3.3.  Market Revenue and Forecast, by Product (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Type (2016-2030)

10.3.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.4.3.      Market Revenue and Forecast, by Product (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Type (2016-2030)

10.3.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.5.3.      Market Revenue and Forecast, by Product (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Type (2016-2030)

10.3.6.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.6.3.      Market Revenue and Forecast, by Product (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Type (2016-2030)

10.3.7.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.7.3.      Market Revenue and Forecast, by Product (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Type (2016-2030)

10.4.2.  Market Revenue and Forecast, by Application (2016-2030)

10.4.3.  Market Revenue and Forecast, by Product (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Type (2016-2030)

10.4.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.4.3.      Market Revenue and Forecast, by Product (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Type (2016-2030)

10.4.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.5.3.      Market Revenue and Forecast, by Product (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Type (2016-2030)

10.4.6.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.6.3.      Market Revenue and Forecast, by Product (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Type (2016-2030)

10.4.7.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.7.3.      Market Revenue and Forecast, by Product (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Type (2016-2030)

10.5.2.  Market Revenue and Forecast, by Application (2016-2030)

10.5.3.  Market Revenue and Forecast, by Product (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Type (2016-2030)

10.5.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.5.4.3.      Market Revenue and Forecast, by Product (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Type (2016-2030)

10.5.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.5.5.3.      Market Revenue and Forecast, by Product (2016-2030)

Chapter 11.  Company Profiles

11.1.              Qiagen

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Thermo Fisher Scientific, Inc.

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Bio-Rad Laboratories, Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              bioMérieux SA

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              F. Hoffmann-La Roche Ltd

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Agilent Technologies, Inc.

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Fluidigm Corporation

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Cytiva

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Stilla Technologies

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Microsynth AG

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

11.11.           JN Medsys

11.11.1.               Company Overview

11.11.2.               Product Offerings

11.11.3.               Financial Performance

11.11.4.               Recent Initiatives

11.12.           Danaher Corporation

11.12.1.               Company Overview

11.12.2.               Product Offerings

11.12.3.               Financial Performance

11.12.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38466

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com